SCHEMBL186470

SCHEMBL186470

N#Cc1ccccc1Nc1ccc(CNC(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
TSHR P16473 2/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MT-CO2 P00403 1/20 0.48
GAA P10253 4/20 0.48
TTK P33981 3/20 0.47
MCL1 Q07820 1/20 0.47
AURKA O14965 2/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.44
GLA P06280 1/20 0.44
LMNA P02545 1/20 0.43
MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806814 0.82 LRRK2 (0.42) TTKMCL1CYP1A2CYP2C19KMT2A
SCHEMBL2807761 0.81 NAMPT (0.51) KDM4ETSHRHPGDHSD17B10GAA
SCHEMBL2809520 0.79 KDM4E (0.41) KDM4ETSHRHSD17B10MT-CO2MCL1
SCHEMBL2810373 0.79 CYP1A2 (0.41) KDM4ETSHRHPGDHSD17B10MCL1
SCHEMBL6176833 0.78 MAPK13 (0.59) KDM4ETSHRHPGDHSD17B10MT-CO2
SCHEMBL4188631 0.77 AURKA (0.59) KDM4ETSHRHPGDHSD17B10GAA
Trifluoroacetic Acid SCHEMBL185638 0.76 TAS2R14 (0.46) KDM4ETSHRHPGDHSD17B10GAA
SCHEMBL2808918 0.76 KMT2A (0.49) KDM4ETSHRHPGDHSD17B10GAA
SCHEMBL2806045 0.76 ACACB (0.45) KDM4EMAPK14SMN1; SMN2
SCHEMBL20552825 0.76 HPGD (0.60) KDM4ETSHRHPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102414177-B Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT 2014-07-02 CN disclosed
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed